Bayer Schering Pharma AG, headquartered in Berlin, is to be managed together with Bayer’s current pharmaceutical business as a division of the Bayer HealthCare subgroup. The resolution necessary for a ...

Germany’s Merck KGaA has agreed to sell its 21.8% stake in Schering AG, paving the way for rival Bayer to seize control of Schering AG. Bayer is expected to pay Merck KGaA $4.6 billion for its ...

BERLIN, January 12, 2009 - Bayer Schering Pharma AG, Germany, has acquired an exclusive option for a collaboration and licensing agreement with Micromet, Inc., a biopharmaceutical company ...

Berlin, May 7, 2010 - Bayer Schering Pharma AG, Germany, today announced that the company has started to enroll patients in an international Phase III trial to evaluate its investigational ...

German pharmaceutical and chemical company Bayer AG said Thursday it would make a $19.5 billion white-knight offer for Schering, bidding against a hostile takeover effort from Merck. Markus ...

"Today's news underlines how important our core technology is to the pharmaceutical industry's drug pipeline," commented Dr. Simon Moroney, Chief Executive Officer of MorphoSys AG. "We now have ...

In Gedeon Richter plc v Bayer Schering Pharma AG [2011] EWHC 583 (Pat), Gedeon Richter plc applied to have two divisional patents belonging to Bayer Schering Pharma AG revoked for invalidity (the ...

SINGAPORE -- German pharmaceutical giant Bayer Schering Pharma AG said Friday it will invest heavily in Asia by doubling its sales team in India and tripling its workforce in Vietnam and that it ...

FRANKFURT (MarketWatch) -- Bayer Schering Pharma AG, die pharmaceutical business of Bayer AG BAY, Friday said it completed the acquisition of a biologics manufacturing facility in Emeryville ...

Bayer AG on Thursday made its official takeover bid for fellow German drugmaker Schering AG, offering $20.01 billion (16.5 billion euros), slightly more than its previous $19.76 billion (16.3 ...